Catalyst Wire Dossier Catalyst Wire Dossier

AVAPRO

irbesartan · Sanofi-Aventis U.S. LLC
Drug timelines are a Plus or Pro feature.

25 regulatory and trial events tracked for AVAPRO, covering 2006-05-18 to 2026-07-24. Get the full timeline:

Most recent: FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)

See pricing